Searchable abstracts of presentations at key conferences in endocrinology

ea0035p360 | Diabetes (epidemiology, pathophysiology) | ECE2014

Atherosclerosis in patients with prediabetes and type 2 diabetes is associated with more significant microcirculation abnormalities

Shyshko Volha , Mokhort Tatjana , Konstantinova Elena , Tsapaeva Nataly

It is known that patients with prediabetes (impaired glucose tolerance and impaired fasting glucose) ant type 2 diabetes (T2D) have micro-and macrovascular complications. It may be assumed that vascular changes begin in the smallest vessels that leads to microcirculation abnormalities.Purpose: To estimate microcirculation abnormalities in patients with prediabetes and T2D and concomitant atherosclerosis.Materials and methods: One h...

ea0035p438 | Diabetes complications | ECE2014

Vascular endothelial growth factor polymorphism +405 G/C is associated with early stage of diabetic nephropathy in patients with type 2 diabetes

Shyshko Volha , Mokhort Tatjana , Gonchar Alexander , Tsapaeva Natalia , Konstantinova Elena

Background: One of the basic genetic factors that impact on development of diabetic nephropathy is enhanced expression of vascular endothelial growth factor (VEGF).Objective: To study association between VEGF polymorphism +405 G/C and early stage of chronic kidney disease (CKD) in patients with impaired glycemic states.Materials and methods: 73 included patients were divided into three groups: group 1–26 patients with prediabe...

ea0032p194 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2013

The activity of inflammation and the blood redox status in patients with coronary heart disease and type 2 diabetes mellitus

Buko Inna , Mokhort Tatiana , Konstantinova Helena , Tsapaeva Natalia , Moiseenok Andrey

To determine the relationship between indicators of inflammation and the blood redox status of type 2 diabetic (T2DM) patients with and without coronary heart disease (CHD).Forty four patients with T2DM and CHD (group 1), 67 patients with T2DM without cardiovascular complications (group 2), 89 healthy subjects (group 3) were included in this study. Serum concentrations of IL6 and IL8 were determined by ELISA using commercial kits. Concentrations of thiob...

ea0029p324 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Myeloperoxidase is not associated with applications of coronary artery disease and type 2 diabetic patients

Mokhort T. , Tsapaeva N. , Buko I. , Konstantinova E. , Shyshko O.

Myeloperoxidase (MPO), an enzyme of the innate immune system, exhibits pro-atherogenic effects and includes influence on oxidative damage to LDL- and HDL-cholesterol, and promotion of endothelial dysfunction.The aim: To investigate the disturbance of MPO in type 2 diabetic (T2D) patients depending on intensity of atherosclerosisMaterial and methods: We investigated 244 patients aged from 45 to 60 years (M±SD 54.0±4.63) in...

ea0081rc6.6 | Rapid Communications 6: Endocrine-Related Cancer | ECE2022

The clinical and molecular evaluation of the GIP/GIPR axis in Medullary Thyroid Cancer (MTC)

Occhi Gianluca , Bertazza Loris , Barollo Susi , Galletta Eva , Mondin Alberto , Zovato Stefania , Iacobone Maurizio , Zilio Eleonora , Avallone Serena , Lefkimmiatis Konstantions , Di Benedetto Giulietta , Mian Caterina , Scaroni Carla , Regazzo Daniela

The glucose-dependent insulinotropic polypeptide receptor (GIPR) is a 7-transmembrane class B G-protein coupled receptor that mediates the incretin response after nutrient stimulation. Although mostly involved in metabolic disorders, in the last years an improper activation of the GIP/GIPR axis has been increasingly recognized in endocrine tumors, with a potential diagnostic and prognostic value. In Medullary Thyroid Cancer (MTC), a neuroendocrine tumor of the parafollicular C...

ea0056p386 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Changes in the glutathione system in patients with impaired carbohydrate metabolism

Shyshko Volha , Mokhort Tatjana , Buko Inna , Konstantinova Elena , Tsapaeva Natalia , Sazonava Alena

Introduction: Many studies have found that markers of oxidative stress (OS) are significantly increased in diabetes mellitus, but only a limited number of studies describe the disturbance of OS in pre-diabetes.Objective: To study the state of the glutathione system in patients with disorders of carbohydrate metabolism and concomitant diseases of the cardiovascular system (CVS).Materials and methods: 181 patients were included under...

ea0073ep217 | Thyroid | ECE2021

Thyroid dysfunction associated with immune checkpoint inhibitors therapy

Mazurina Natalya , Glibka Anastasiya , Troshina Ekaterina , Laktionov Konstantine , Kharkevich Galina , Sarantseva Kseniya , Kruteleva Svetlana

IntroductionProspective and retrospective trials report the incidence of endocrine adverse events provoked by immune checkpoint inhibitors (ICI) up to 30%. PD-1/PDL inhibitors have a higher incidence of thyroid dysfunction: hypothyroidism 5%-14%, transient hyperthyroidism – 3%-5%.The aim of the study was to assess thyroid function in PD-1/PDL treated patients.Materials and methods6...

ea0089t8 | Trials In Progress | NANETS2022

Phase II Trial Evaluating [177Lu]Lu-DOTA-TATE in Adolescents with Somatostatin Receptor (SSTR)-positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs), Pheochromocytomas and Paragangliomas (PPGLs)

Chauhan Aman , Sue O'Dorisio M. , Gaze Mark , Sabado Constantino , Brouri Fazia , Xu Lingfei

Background: GEP-NETS and PPGLs in pediatric patients are rare; however, recognition of these diseases has increased recently. 10–20% of pediatric patients with GEP-NETs and up to 47% of pediatric patients with PPGLs present with metastatic disease at diagnosis. The disease is often unresectable with poor prognosis, and very few non-surgical therapies are approved for these patients. Due to paucity of data surrounding treatments for pediatric patients with advanced GEP-NET...

ea0026p572 | Cardiovascular endocrinology and lipid metabolism | ECE2011

Phosphate levels inversely correlate with aortic stiffness in patients with primary hyperparathyroidism

Athanasouli Fanni , Papadopoulos Leonidas , Vemmou Anastasia , Chalaris Konstantine , Efthimiou Evelin , Athanasoulis Theodore , Papamichael Christos , Stamatelopulos Kimon , Terpos Evangelos , Alevizaki Maria

Introduction: Although data on the association of primary hyperparathyroidism (pHPT) with cardiovascular disease are accumulating, there is still controversy on this issue. Moreover, possible associations of aortic stiffness and central aortic pressures with pHPT and associated effective molecules have not been addressed.Methods: Seventy patients with pHPT were consecutively recruited from the outpatients’ clinic of an academic department of endocri...

ea0070ep449 | Thyroid | ECE2020

Esophageal perforation due to thyroid lymphoma

Anagnostis Panagiotis , Vaitsi Konstantina , Tzelepi Keraso , Kalaitzis Efstratios

Introduction: Primary thyroid lymphoma (PTL) represents about 1–5% of thyroid malignancies and < 2% of extra-nodal lymphoma. The most common subtype is diffuse large B-cell lymphoma (DLBCL) (~ 50% of cases), followed by mucosa-associated lymphoid tissue (MALT) lymphoma, both non-Hodgkin’ lymphomas. sophageal perforation is a very rare complication during the course of PTL, characterized by poor prognosis.Case presentation: A 65-year-...